Tag: Safety
Over-The-Counter Eye Drops and Nasal Sprays: Drug Safety Communication – Serious Adverse Events From Accidental Ingestion by Children
Accidental ingestion of active ingredients tetrahydrozoline, oxymetazoline, or naphazoline may cause serious and life-threatening adverse events. MedWatch Safety Alert RSS Feed
New Safety Information: Interaction of Proton Pump Inhibitors (PPIs) with Methotrexate
Health Canada is informing Canadians and Canadian health care practitioners that the labelling for methotrexate and Proton Pump Inhibitors is being updated to include information on a potential interaction between these products. The new information will be in the “Warnings and Precautions” section of the methotrexate and the PPIs labelling. Health Canada RSS – MedEffect [...]
Stryker Instruments Neptune 1 Silver and Neptune 2 Ultra Waste Management System (Neptune 1 Silver and Neptune 2 Ultra): Safety Communication – Reports of Serious Tissue Damage
Incorrect use can cause hemorrhaging and soft tissue, muscle, and vital organ damage, which can lead to serious injury and/or death. MedWatch Safety Alert RSS Feed
Reminding Canadians of Turkey Safety This Thanksgiving
Cooked turkey is a central part of many holiday celebrations in Canada – especially Thanksgiving. Health Canada would like to remind all Canadians of some steps they can take to help ensure their turkey feast is a safe one. Health Canada RSS – Media Room
Reminding Canadians of Potential Safety Concerns with Home Canning
Health Canada would like to remind Canadians of the importance of good food safety practices while home canning Health Canada RSS – Media Room
Mirapex (pramipexole): Drug Safety Communication – Ongoing Safety Review, Possible Risk of Heart Failure
FDA currently evaluating analysis of randomized clinical trials and epidemiologic studies. MedWatch Safety Alert RSS Feed
Intestinomicina (contains chloramphenicol) by Laboratorios Lopez: Safety Alert – Contains Drug Ingredient Withdrawn from US
Intestinomicina contains chloramphenicol, drug ingredient withdrawn from the US due to the risk of serious and life threatening injuries. MedWatch Safety Alert RSS Feed
FDA Drug Safety Communication: Rare cases of serious burns with the use of over-the-counter topical muscle and joint pain relievers
The U.S. Food and Drug Administration (FDA) is alerting the public that certain over-the-counter (OTC) products that are applied to the skin for the relief of mild muscle and joint pain have been reported to cause rare cases of serious skin injuries, ranging from first- to third-degree chemical burns, where the products were applied. What’s [...]
Over-The-Counter Topical Muscle and Joint Pain Relievers: Drug Safety Communication – Rare Cases of Serious Burns
Some of the burns had serious complications requiring hospitalization MedWatch Safety Alert RSS Feed
FDA Drug Safety Communication: FDA recommends against use of Revatio in children with pulmonary hypertension
The U.S. Food and Drug Administration (FDA) is recommending that Revatio (sildenafil) not be prescribed to children (ages 1 through 17) for pulmonary arterial hypertension (PAH; high pressure in the blood vessels leading to the lungs). What’s New: Drugs RSS Feed
